Adage Capital Partners Gp, L.L.C. Precigen, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $56.4 Billion
- Q2 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Precigen, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 11,276,000 shares of PGEN stock, worth $37.3 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
11,276,000
Previous 11,276,000
-0.0%
Holding current value
$37.3 Million
Previous $16.8 Million
4.7%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding PGEN
# of Institutions
165Shares Held
166MCall Options Held
511KPut Options Held
1M-
Third Security, LLC83.5MShares$276 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD16.3MShares$53.8 Million1.22% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$33.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.07MShares$30 Million0.0% of portfolio
-
Iridian Asset Management LLC4.28MShares$14.2 Million2.21% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $689M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...